Filing metadata

Accession number
0001209191-22-032523
Form type
Form 4
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
May 27, 2022
Reporting period
May 26, 2022
Description
Insider transaction

Explore SEC Filings Hub